Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy -- Ignore unavailable to you. Want to Upgrade?

To: Jim Oravetz who wrote (218)	1/16/2001 10:28:26 PM
From: JMarcus	Read Replies (1) \| Respond to of 370

I just came across a rather nice 32-page research paper (free) on VION at www.dirtydozenresearch.com

To: Jim Oravetz who wrote (218)	1/22/2001 4:55:35 PM
From: Dave	Read Replies (1) \| Respond to of 370

I would like to invest in VION long-term, but I'm concerned about their short and medium-term survival. They've got exciting products in the pipeline, but will they stay afloat long enough for these products to be tested and approved? This company loses over $10 million a year, and has less than $30 million in cash and investments. Assuming it will be more than three years before they become profitable, how will they skirt their creditors and avoid bankruptcy? Dave